Steven Tau
Steven Tau has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Todd W. Miller
Department of Molecular & Systems Biology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
138 shared publications - Eugene Demidenko
Dartmouth College
137 shared publications - Alyssa M. Roberts
Department of Molecular and Systems Biology, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire
136 shared publications - Fred Kolling
Dartmouth College
136 shared publications - Jonathan D. Marotti
Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
136 shared publications - Shannon Margaret Soucy
Department of Biomedical Data Science, Geisel School of Medicine, Hanover, NH, 03755, USA
136 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Suppl. Figure 4 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Suppl. Figure 4 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSuppl. Figure 4 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Suppl. Figure 4 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Suppl. Figure 5 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Suppl. Figure 5 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSuppl. Figure 5 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Suppl. Figure 5 from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Clinical study protocol (version 11October2021)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer
Clinical study protocol (version 11October2021)